Not Signed In -
Epirubicin Injection |
Ellence; epirubicin |
Epirubicin Systematic (IUPAC) name 10-(4-amino-5-hydroxy-6-methyl-oxan-2-yl) oxy-6,8,11-trihydroxy-8-(2-hydroxyacetyl)- 1-methoxy-9,10-dihydro-7H-tetracene-5,12-dione Identifiers CAS number 56420-45-2 ATC code L01DB03 PubChem 41867 DrugBank APRD00361 Chemical data Formula C27H29NO11 Mol. weight 543.519 g/mol Pharmacokinetic data Bioavailability NA Protein binding 77% Metabolism Hepatic glucuronidation and oxidation Half life ? Excretion Bili ...
Wikipedia - [full article]
Epirubicin Injection Clinical Trials
- Adjuvant Epirubicin/Cytoxan Followed by a Taxane Vs. Epirubicin/Taxane as Treatment for Node-Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00140075 - Active, not recruiting
Adenocarcinoma
- An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 Using Epirubicin Clearance and the Ratios of Epirubicin and Epirubicinol Glucuronide to Epirubicin.
ClinicalTrials.gov Identifier: NCT00131612 - Active, not recruiting
-breast cancer
- Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00002953 - Active, not recruiting
stage IV breast cancer
- Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00020748 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer
ClinicalTrials.gov Identifier: NCT00003577 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
Ovarian Neoplasms
- Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00062296 - Active, not recruiting
adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia
- Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00002866 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Neutropenia
- Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
ClinicalTrials.gov Identifier: NCT00075465 - Active, not recruiting
adenocarcinoma of the stomach; stage III gastric cancer; stage IV gastric cancer
- Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00017186 - Active, not recruiting
localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
- Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)
ClinicalTrials.gov Identifier: NCT00544232 - Active, not recruiting
Breast Cancer
- Gemcitabine/Cisplatin Vs Gemcitabine/Epirubicin for NSCLC
ClinicalTrials.gov Identifier: NCT00154739 - Recruiting
Non-small cell lung cancer
- Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00010140 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women With Early Breast Cancer
ClinicalTrials.gov Identifier: NCT00070278 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma Cancer
ClinicalTrials.gov Identifier: NCT00057980 - Active, not recruiting
advanced adult primary liver cancer; localized unresectable adult primary liver cancer; adult primary hepatocellular carcinoma
- Combined Phase I/II Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer with Pharmacogenet
ClinicalTrials.gov Identifier: NCT00130936 - Recruiting
-gastric cancer; -esophageal cancer; -solid tumors
- EC (Epirubicin, Cyclophosphamide) Followed by T (Docetaxel) Vs. ET (Epirubicin, Docetaxel) Followed by X (Capecitabine) as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Patients.
ClinicalTrials.gov Identifier: NCT00129935 - Completed
Breast cancer.
- Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00072319 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- Phase I Combination w/ Epirubicin
ClinicalTrials.gov Identifier: NCT00322374 - Recruiting
Metastatic Breast Cancer
- Docetaxel and Epirubicin in Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00375999 - Recruiting
Stomach Neoplasms
- Phase I- Lapatinib and Epirubicin Study
ClinicalTrials.gov Identifier: NCT00566748 - Recruiting
Metastatic Breast Cancer
- Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00096304 - Recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Neo-Adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00193206 - Active, not recruiting
Breast Cancer
- Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00193050 - Active, not recruiting
Breast Cancer
- Cytoxan, Epirubicin and Capecitabine in Women with Breast Cancer
ClinicalTrials.gov Identifier: NCT00146588 - Active, not recruiting
Breast Cancer; stage I breast cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer
- Penile Injection Anxiety
ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
- Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
ClinicalTrials.gov Identifier: NCT00246103 - Recruiting
Neoplams, Advanced
- A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00123318 - Active, not recruiting
Gastric Cancer
- Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00364754 - Active, not recruiting
Metastatic/Recurrent Breast Cancer
- Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
Myocardial Infarction
- Therapy with Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients with Breast Cancer
ClinicalTrials.gov Identifier: NCT00110695 - Active, not recruiting
Breast Neoplasms
- Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00066443 - Recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
- A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
- Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
ClinicalTrials.gov Identifier: NCT00021047 - Active, not recruiting
Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gastric Cancer; Head and Neck Cancer; Liver Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
Myelodysplastic Syndromes
- High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
ClinicalTrials.gov Identifier: NCT00002784 - Active, not recruiting
Breast Cancer
- Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00398489 - Recruiting
Breast Cancer
- Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00431795 - Recruiting
Breast Cancer
- Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00516425 - Recruiting
Breast Cancer
- A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
ClinicalTrials.gov Identifier: NCT00218205 - Recruiting
Prostate Cancer
- Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
- Combination Chemotherapy in Treating Women With Stage I Breast Cancer
ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
stage I breast cancer
- Adverse Drug Reactions of Different Brands of Ceftazidime Injection
ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
Infection
- Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00002529 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer
- Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery
ClinicalTrials.gov Identifier: NCT00039546 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
Pain
- Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00379015 - Recruiting
Breast Cancer
- Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00486356 - Recruiting
Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Validation of Self-Reported Needle Sharing Among Injection Drug Users
ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
Viral Infection
- Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00003012 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer
- Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00003893 - Active, not recruiting
stage I breast cancer
- Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
ClinicalTrials.gov Identifier: NCT00309556 - Recruiting
Early-Stage Breast Cancer
- EPC by Intracoronary Injection in Patients With Chronic Stable Angina
ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
Coronary Artery Disease
- Evaluation of Differing Taxanes/Taxane Combinations on the Outcomes of Patients with Operable Breast Cancer
ClinicalTrials.gov Identifier: NCT00050167 - Recruiting
Breast Cancer
- A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
- High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00002870 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Quality of Life
- Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00003606 - Active, not recruiting
extensive stage small cell lung cancer
- Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00464646 - Recruiting
Breast Cancer
- Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00176488 - Recruiting
Breast Cancer
- The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
- Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer
ClinicalTrials.gov Identifier: NCT00004237 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Combination Chemotherapy in Treating Women With Resected Breast Cancer
ClinicalTrials.gov Identifier: NCT00033683 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
ClinicalTrials.gov Identifier: NCT00038402 - Recruiting
Breast Cancer
- Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
Type A Botulinum Toxin; Tennis Elbow
- Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004873 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer
- Tamoxifen in Treating Patients With High-Risk Breast Cancer
ClinicalTrials.gov Identifier: NCT00002542 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Study of Alimta and Epirubicin Administered in Patients with Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00097383 - Completed
Breast Cancer
- Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
Myocardial Infarction; Heart Failure, Congestive
- Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
Psoriasis
- A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
Schizophrenia
- IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
Glaucoma; Intraocular Pressure
- Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
HIV Infections; Hepatitis C
- Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
Neovascular Glaucoma
- Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
ClinicalTrials.gov Identifier: NCT00022178 - Active, not recruiting
squamous cell carcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; undifferentiated carcinoma of unknown primary; ...
- A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
HCV Negative Status; HCV Risk Behavior
- A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
Recovery Following Partial Medial Meniscectomy
- Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
Colorectal Neoplasms
- Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00054587 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer
- Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma
ClinicalTrials.gov Identifier: NCT00002898 - Active, not recruiting
Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma
- Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel
ClinicalTrials.gov Identifier: NCT00527449 - Recruiting
Primary Breast Cancer
- Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00053911 - Active, not recruiting
recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
Breast Cancer
- Vitamin K Injections for the Treatment of Painful Menstruation
ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
Dysmenorrhea
- Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00002615 - Active, not recruiting
stage II gastric cancer; stage III gastric cancer; adenocarcinoma of the stomach
- Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00014222 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
- Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer
ClinicalTrials.gov Identifier: NCT00005583 - Active, not recruiting
stage I endometrial cancer; stage II endometrial cancer; endometrial adenocarcinoma; endometrial papillary carcinoma; ...
- Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00008034 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage II breast cancer
- Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
Melanoma
- Predictors for Response to Dose-Dense Docetaxel and Epirubicin Breast Cancer
ClinicalTrials.gov Identifier: NCT00496795 - Not yet recruiting
Primary Breast Cancer
- Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00005581 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer; Quality of Life
- Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
Tuberculosis
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00005584 - Active, not recruiting
stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; adult lymphocyte predominant Hodgkin's lymphoma
- Docetaxel Followed by CEF (cyclophosphamide, epirubicin and 5-fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (cyclophosphamide, epirubicin and capecitabine) as Adjuvant Treatment for Breast Cancer
ClinicalTrials.gov Identifier: NCT00114816 - Completed
Breast Cancer
- Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
Hepatocellular Carcinoma
- Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
Carcinoid Tumor; Acromegaly
- Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
ClinicalTrials.gov Identifier: NCT00025441 - Active, not recruiting
childhood rhabdomyosarcoma; childhood soft tissue sarcoma; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma
- Patients Preference With Self-Injection: The PRISM Study
ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
Bruises
- Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
Hemorrhagic Shock
- Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
Diabetic Macular Edema
- Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
Type 2 Diabetes Mellitus
Resources
- Ellence (Drug Digest)
- Ellence Consumer Information (U.S. Food and Drug Administration)
email this page
print this page
bookmark this page
feedback on this page
